The role of drugs for weight reduction in stages management of type 2 diabetes: focus on sibutramine
AbstractAuthors of the article present the epidemiological and pathogenetic aspects of the relationship of type 2 diabetes and obesity, argue for the possibility of including drugs for weight loss in the current recommendations for the treatment of type 2 diabetes with obesity. We consider the case of a real clinical use of sibutramine in combination with metformin, a patient with newly diagnosed type 2 diabetes.
Keywords:diabetes, obesity, sibutramine
Endocrinology: News, Opinions, Training. 2017; (1): 52–59.
DOI: 10.24411/2304-9529-2017-00025